UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000037749 |
|---|---|
| Receipt number | R000042970 |
| Scientific Title | A placebo-controlled, double-blind, randomized phase III study to validate the efficacy of standard antiemetic therapy plus olanzapine for the prevention of chemotherapy-induced nausea and vomiting associated with chemotherapy including carboplatin |
| Date of disclosure of the study information | 2019/09/01 |
| Last modified on | 2024/03/06 15:03:58 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2019/08/20 23:21:26 | ||
| 2 | Update | 2020/01/14 10:38:45 | Recruitment status |
|
| 3 | Update | 2024/03/06 13:16:32 | Recruitment status |
|
| 4 | Update | 2024/03/06 15:03:58 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
